Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Mar 18, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 17
- −3 vs. Q3 2025
- Portfolio value
- $555.0M
- +$51.1M (+10.1%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $213.9M | 38.5% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 5,623,816 | $130.0M | 23.4% | 00.0% | Unchanged | History |
| RAPPRapport Therapeutics, Inc. | COM | 1,784,517 | $54.1M | 9.8% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 6,641,064 | $52.8M | 9.5% | 00.0% | Unchanged | History |
| CVRXCVRx, Inc. | COM | 4,024,861 | $28.6M | 5.1% | −78,569−1.9% | Reduced | History |
| CTNMContineum Therapeutics, Inc. | CL A | 1,979,173 | $22.6M | 4.1% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 814,586 | $17.7M | 3.2% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 748,062 | $11.5M | 2.1% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 357,939 | $11.3M | 2.0% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $3.32M | 0.6% | 00.0% | Unchanged | History |
| NMRANeumora Therapeutics, Inc. | COM | 1,849,445 | $3.31M | 0.6% | 00.0% | Unchanged | History |
| RLYBRallybio Corp | COM | 3,636,363 | $2.49M | 0.4% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM NEW | 54,887 | $1.69M | 0.3% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM NEW | 53,732 | $702.8K | 0.1% | +53,732 | New | History |
| NNOXNano-X Imaging Ltd. | ORD SHS | 158,852 | $444.8K | 0.1% | 00.0% | Unchanged | History |
| LABStandard Biotools Inc. | COM | 311,967 | $399.3K | 0.1% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM NEW | 22,779 | $191.8K | <0.1% | +22,779 | New | History |
Sold out since Q3 2025 (5)
Positions held at the end of Q3 2025 that are gone from this filing.
| Security | Class | Shares in Q3 2025 | Value in Q3 2025 | % of portfolio in Q3 2025 | History |
|---|---|---|---|---|---|
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 247,598 | $8.54M | 1.7% | History |
| VORVor Biopharma Inc. | COM | 53,732 | $2.62M | 0.5% | History |
| ACETAdicet Bio, Inc. | COM | 364,472 | $295.3K | 0.1% | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 96,866 | $50.9K | <0.1% | History |
| SENSSenseonics Holdings, Inc. | COM | 54,621 | $23.8K | <0.1% | History |